Edgewise Therapeutics Inc. Common Stock vs Teradata Corporation Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.13 (market cap $3.94B), while Teradata Corporation Common Stock trades at $29.6 (market cap $2.83B). The key difference: Edgewise Therapeutics Inc. Common Stock is the larger of the two by market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Teradata Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Teradata Corporation Common Stock for 0 Days on average.
| EWTX | TDC | |
|---|---|---|
Market Cap | $3.94B | $2.83B |
Volume | 810,104 | 1,343,944 |
Sector | Health | Technology |
52-Week High | $48.35 | $37.88 |
52-Week Low | $14.89 | $20.71 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $2.52B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Teradata Corporation develops a hybrid cloud analytics and data platform, including its Teradata Vantage and VantageCloud products, that helps enterprises manage and analyze data across cloud, on-premises, and hybrid environments. It serves industries including retail, financial services, healthcare, and manufacturing.
Read more on TDC →